Live Quote · NASDAQKTTAHealthcare· Biotechnology

Pasithea Therapeutics Corp.

$0.55 3.02%($-0.02)
TickerSpark Score
59/100
Mixed
100
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KTTA research report →

52-Week Range15% of range
Low
$0.28
Current
$0.55
High
$2.06
Company Overviewwww.pasithea.com

About the company

Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment.

CEO
Tiago Reis Marques
IPO
2021
Employees
4
HQ
Miami Beach, FL, US

Price Chart

-26.48% · this period
$1.47$0.88$0.29Jul 02Dec 31Jul 02
Valuation
Market Cap
$4.09M
P/E
-0.23
P/S
0.00
P/B
0.07
EV/EBITDA
2.16
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-57.44%
ROIC
-40.20%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-20,427,683 · -46.91%
EPS
$-2.91 · 77.07%
Op Income
$-20,857,295
FCF YoY
-109150.95%
Performance & Tape
52W High
$2.06
52W Low
$0.28
50D MA
$0.67
200D MA
$0.80
Beta
0.25
Avg Volume
864.41K

Get TickerSpark's AI analysis on KTTA

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 17, 26Coastlands Capital LPbuy100,000
May 1, 26Marques Tiagoother1,756,069
May 1, 26STEINMAN LAWRENCEother152,783
May 1, 26Dumesnil Simonother152,783
May 1, 26Schneiderman Daniel Hother1,129,323
May 1, 26Krishnan Kartikother1,129,323
May 1, 26Leahy Emerother152,783
May 1, 26Novak Alfred Jother152,783
May 1, 26Krishnan Kartikother0
Apr 9, 26Coastlands Capital LPother0
Coverage · KTTA

Our KTTA coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on KTTA yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate KTTA report →
Internal Compare

Similar companies

Peers in the same neighborhood.